Exelixis
EXEL
#1725
Rank
$9.50 B
Marketcap
$33.29
Share price
-1.16%
Change (1 day)
41.78%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: $9.50 Billion USD

As of December 2024 Exelixis has a market cap of $9.50 Billion USD. This makes Exelixis the world's 1725th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024$9.50 B27.43%
2023$7.46 B44.19%
2022$5.17 B-10.54%
2021$5.78 B-7.11%
2020$6.22 B16.3%
2019$5.35 B-9.24%
2018$5.89 B-34.42%
2017$8.99 B108.06%
2016$4.32 B236.22%
2015$1.28 B355.78%
2014$0.28 B-75.06%
2013$1.13 B34.75%
2012$0.83 B30.78%
2011$0.64 B-28.46%
2010$0.89 B12.81%
2009$0.79 B50.04%
2008$0.53 B-41.36%
2007$0.90 B4.63%
2006$0.86 B9.96%
2005$0.78 B10.28%
2004$0.71 B41.74%
2003$0.50 B5.8%
2002$0.47 B-49.09%
2001$0.93 B36.54%
2000$0.68 B

End of Day market cap according to different sources

On Dec 21st, 2024 the market cap of Exelixis was reported to be:

$9.50 Billion USD
by Nasdaq info icon info icon
$9.50 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$69.53 B 631.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
$121.30 B 1,175.99%๐Ÿ‡ซ๐Ÿ‡ท France
$248.03 B 2,508.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$116.27 B 1,123.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$141.57 B 1,389.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$347.82 B 3,558.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$149.38 B 1,471.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.07 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.52 B-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA